Physician profile
John Beronio
NPI 1710934278
$1,067.94
in general payments reported to CMS, 2019-2025
19 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $102 · 2020: $208 · 2021: $64.47 · 2022: $236 · 2023: $104 · 2024: $247 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $458.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $458.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $299.80 | 2022-2024 | |
| Kerecis Limited | $101.16 | 2019-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Sandoz INC. | $93.91 | 2019-2021 | |
| Stryker Corporation | $87.33 | 2020-2025 | Prostep Mica |
| Integra Lifesciences Corporation | $67.50 | 2019-2020 | |
| Orthofix Medical, INC. | $56.18 | 2024-2025 | Physio-Stim |
| Depuy Synthes Sales INC. | $53.60 | 2022-2025 | Motoband |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $42.91 | 2020-2024 | Jublia |
| Musculoskeletal Transplant Foundation INC. | $38.71 | 2023-2024 | |
| Paratek Pharmaceuticals, INC. | $29.18 | 2023-2024 | Nuzyra |
| Horizon Therapeutics Plc | $28.79 | 2021 | |
| Convatec INC. | $27.69 | 2024 | |
| Zimmer Biomet Holdings, INC. | $26.95 | 2020 | |
| Sebela Pharmaceuticals INC. | $25.60 | 2020 | |
| Smith+Nephew, INC. | $23.91 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $22.32 | 2022 | |
| Heron Therapeutics, INC. | $20.40 | 2021 | |
| Reprise Biomedical, INC. | $11.00 | 2025 | Miro3d |
| Glenmark Therapeutics INC. | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Beronio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.